Zhao H - Search Results

1

1H-Pyrazolo-[3,4-c]cyclophepta[1,2-c]thiophenes: a unique structural class of dopamine D4 selective ligands.

Thurkauf A, Chen X, Zhang S, Gao Y, Kieltyka A, Wasley JW, Brodbeck R, Greenlee W, Ganguly A, Zhao H. Thurkauf A, et al. Among authors: zhao h. Bioorg Med Chem Lett. 2003 Sep 1;13(17):2921-4. doi: 10.1016/s0960-894x(03)00587-0. Bioorg Med Chem Lett. 2003. PMID: 14611858

2

Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships.

Zhao H, Thurkauf A, He X, Hodgetts K, Zhang X, Rachwal S, Kover RX, Hutchison A, Peterson J, Kieltyka A, Brodbeck R, Primus R, Wasley JW. Zhao H, et al. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3105-9. doi: 10.1016/s0960-894x(02)00655-8. Bioorg Med Chem Lett. 2002. PMID: 12372512

3

Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.

Zhao H, He X, Thurkauf A, Hoffman D, Kieltyka A, Brodbeck R, Primus R, Wasley JW. Zhao H, et al. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3111-5. doi: 10.1016/s0960-894x(02)00656-x. Bioorg Med Chem Lett. 2002. PMID: 12372513

4

Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: a novel series of mixed dopamine D2/D4 receptor antagonist.

Zhao H, Zhang X, Hodgetts K, Thurkauf A, Hammer J, Chandrasekhar J, Kieltyka A, Brodbeck R, Rachwal S, Primus R, Manly C. Zhao H, et al. Bioorg Med Chem Lett. 2003 Feb 24;13(4):701-4. doi: 10.1016/s0960-894x(02)01056-9. Bioorg Med Chem Lett. 2003. PMID: 12639562

5

Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.

Zhao H, Thurkauf A, Braun J, Brodbeck R, Kieltyka A. Zhao H, et al. Bioorg Med Chem Lett. 2000 Sep 18;10(18):2119-22. doi: 10.1016/s0960-894x(00)00421-2. Bioorg Med Chem Lett. 2000. PMID: 10999484

6

trans-1-[(2-Phenylcyclopropyl)methyl]-4-arylpiperazines: mixed dopamine D(2)/D(4) receptor antagonists as potential antipsychotic agents.

Zhang X, Hodgetts K, Rachwal S, Zhao H, Wasley JW, Craven K, Brodbeck R, Kieltyka A, Hoffman D, Bacolod MD, Girard B, Tran J, Thurkauf A. Zhang X, et al. Among authors: zhao h. J Med Chem. 2000 Oct 19;43(21):3923-32. doi: 10.1021/jm990562x. J Med Chem. 2000. PMID: 11052797

7

Aminopyrazine CB1 receptor inverse agonists.

Wustrow DJ, Maynard GD, Yuan J, Zhao H, Mao J, Guo Q, Kershaw M, Hammer J, Brodbeck RM, Near KE, Zhou D, Beers DS, Chenard BL, Krause JE, Hutchison AJ. Wustrow DJ, et al. Among authors: zhao h. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3376-81. doi: 10.1016/j.bmcl.2008.04.022. Epub 2008 Apr 13. Bioorg Med Chem Lett. 2008. PMID: 18448340

8

The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.

DeMong D, Dai X, Hwa J, Miller M, Lin SI, Kang L, Stamford A, Greenlee W, Yu W, Wong M, Lavey B, Kozlowski J, Zhou G, Yang DY, Patel B, Soriano A, Zhai Y, Sondey C, Zhang H, Lachowicz J, Grotz D, Cox K, Morrison R, Andreani T, Cao Y, Liang M, Meng T, McNamara P, Wong J, Bradley P, Feng KI, Belani J, Chen P, Dai P, Gauuan J, Lin P, Zhao H. DeMong D, et al. Among authors: zhao h. J Med Chem. 2014 Mar 27;57(6):2601-10. doi: 10.1021/jm401858f. Epub 2014 Feb 26. J Med Chem. 2014. PMID: 24527772

9

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.

Greenlee W, Clader J, Asberom T, McCombie S, Ford J, Guzik H, Kozlowski J, Li S, Liu C, Lowe D, Vice S, Zhao H, Zhou G, Billard W, Binch H, Crosby R, Duffy R, Lachowicz J, Coffin V, Watkins R, Ruperto V, Strader C, Taylor L, Cox K. Greenlee W, et al. Among authors: zhao h. Farmaco. 2001 Apr;56(4):247-50. doi: 10.1016/s0014-827x(01)01102-8. Farmaco. 2001. PMID: 11421251 Review.

10

Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.

Zhu W, Sun C, Xu S, Wu C, Wu J, Xu M, Zhao H, Chen L, Zeng W, Zheng P. Zhu W, et al. Among authors: zhao h. Bioorg Med Chem. 2014 Dec 15;22(24):6746-54. doi: 10.1016/j.bmc.2014.11.003. Bioorg Med Chem. 2014. PMID: 25468038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34,049 results

Search Page